Faulty signaling in brain increases craving for sugar and drugs

August 30, 2011 in Neuroscience

When glutamate and dopamine do not collaborate as they should in the brain's signal system, the kick that alcohol, sugar, or other drugs induce increases. This is shown in a new Swedish-Canadian study on mice being published today in the prestigious Journal of Neuroscience. It provides a key piece of the puzzle about the mechanisms behind both substance abuse and obesity.

"Our data indicate that the brain becomes hypersensitive to rewards when this co-signaling of glutamate and dopamine does not function. Lower doses than normal are enough to increase the propensity to ingest the substance, and this is true of both sugar and ," says Asa Mackenzie, associate professor of neuroscience at Uppsala University and the researcher who led the study.

Addiction disorders are a major social problem, and we lack sufficient knowledge of how they arise and how various substances impact the brain. The brain's reward system gives us feelings of pleasure and happiness, for example when we have eaten or drunk something good, had sex, or worked out. This pleasure arises when certain signal substances, primarily dopamine, are released in the brain. But this reward system can be "kidnapped" by other rewarding substances, such as alcohol and abuser drugs like cocaine. They provide feelings of reward initially, but they are so strong that in the system are rewired, and addiction occurs. More , such as food rich in sugar, can also produce addiction-like conditions.

The Uppsala researchers and their colleagues have recently shown that dopamine cells in the reward system can send signals in cooperation with glutamate, so called co-signaling. Its physiological role was not previously known, however. For instance, how important is it for the inclination to ingest reward substances?

In studies of mice that lack the ability to send the above signals because their glutamate transporter, so-called VGLUT, has been inactivated, the scientists studied how prone the mice were to ingest sugar and cocaine. The results showed that they both ingested more and responded to lower dosages than control mice.

Since there is a strong correlation between memory and consumption substances, and ultimately also for the risk of addiction, the researchers also looked into this. They are able to present the interesting finding from the study that mice that lack the ability to co-signal developed dramatically improved memory of environments that could be associated with the ingestion of drugs. They also found changes in genetic expressions in the that indicate that the brain has become hypersensitive and that dopamine levels have dropped.

"This is extremely interesting, but more research is needed in order to understand how this can be used in drug development, for instance," says Asa Mackenzie.

These scientists have now gone on to study these mechanisms in connection with abuse in humans and are looking for direct connections between low VGLUT levels and addiction.

Provided by Uppsala University search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Neuroscience created 4 hours ago | popularity 5 / 5 (3) | comments 0 | with audio podcast

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Neuroscience created 7 hours ago | popularity 4.8 / 5 (6) | comments 0 | with audio podcast report

Waiting for a sign? Researchers find potential brain 'switch' for new behavior

You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when ...

Neuroscience created 8 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Neuroscience created 9 hours ago | popularity 4 / 5 (4) | comments 0 | with audio podcast report

Study shows where scene context happens in our brain

In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...

Neuroscience created 11 hours ago | popularity 4 / 5 (1) | comments 0 | with audio podcast


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

Biomarkers discovered for inflammatory bowel disease

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...